Beta-blocker treatment in heart failure. Role of heart rate reduction
Reference58 articles.
1. Aarons RD, Nies AS, Gal J, Hegestrand LR, Molinoff PB (1980) Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest 65: 949–957
2. Anderson JL, Lutz JR, Gilbert EM, Sorensen SG, Yanowitz FG, Menlove RL, Bartholomew M (1985) A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 55: 471–75
3. Australia-New Zealand Heart Failure Research Collaborative Group (1995) Effects of Carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease, Circulation 92: 212–18
4. The Best Steering committee (1995) Design of the Beta-Blocker Evaluation Survival Trial. Am J Cardiol 75: 1220–1223
5. Bristow MR, Anderson FL, Port JD, Skesl L, Hershberger RE, Larrabee P, O’Connell JB, Renlund DG, Volkman K, Murray J, Feldman AM (1991) Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 84: 1024–1039